Form D · Biotechnology

Lanier Biotherapeutics, Inc.

Bogart, GA · CIK 0001877210

Offering snapshot reported Nov 7, 2022 · SEC filing

Reported sold
$3.05M
Offering amount: $4.92M
Investors reported
47
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jul 28, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.53M$3.05MAug 6, 2021: $805,000.00Aug 6, 2021Nov 7, 2022: $3,050,371.00Nov 7, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$805,000 → $3,050,371

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 7, 2022Amendment$3,050,371$2,245,371vs Aug 6, 202147SEC filing
Aug 6, 2021Initial$805,000No comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-409084

Source: Form D, filed Nov 7, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kirby N. Alton Director
Christopher Mc Leod Director
Lewis Scruggs Director
Martin A. Simonetti Director
Daniel White Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
150 Ben Burton Road
Bogart, GA, 30622